Crinetics Pharmaceuticals (CRNX) Institutional Ownership $32.33 -0.75 (-2.27%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$32.35 +0.02 (+0.06%) As of 06/11/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Crinetics Pharmaceuticals (NASDAQ:CRNX)CurrentInstitutional OwnershipPercentage98.51%Number ofInstitutional Buyers(last 12 months)155TotalInstitutional Inflows(last 12 months)$1.28BNumber ofInstitutional Sellers(last 12 months)84TotalInstitutional Outflows(last 12 months)$485.58M Get CRNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRNX Institutional Buying and Selling by Quarter Crinetics Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers131,950$4.43M0.0%+6.3%0.141% 5/28/2025 Strs Ohio3,700$124K0.0%N/A0.004% 5/20/2025 Intech Investment Management LLC56,950$1.91M0.0%+32.1%0.061% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC347,581$11.66M0.0%+6.9%0.371% 5/16/2025 Exome Asset Management LLC51,295$1.72M1.5%N/A0.055% 5/16/2025 Goldman Sachs Group Inc.499,594$16.76M0.0%-30.7%0.534% 5/16/2025 Kestra Investment Management LLC2,839$95K0.0%N/A0.003% 5/16/2025 Parkman Healthcare Partners LLC63,940$2.15M0.3%+25.0%0.068% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.59,311$2.00M0.0%+11.6%0.063% 5/16/2025 Cormorant Asset Management LP600,000$20.12M1.5%-40.0%0.641% Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Advisors Asset Management Inc.6,674$224K0.0%+35.8%0.007% 5/16/2025 AWM Investment Company Inc.95,000$3.19M0.4%+72.7%0.101% 5/15/2025 First Light Asset Management LLC855,419$28.69M3.3%-3.4%0.914% 5/15/2025 Vestal Point Capital LP1,500,000$50.31M3.6%N/A1.602% 5/15/2025 MPM Bioimpact LLC631,964$21.20M3.6%+2.4%0.675% 5/15/2025 Royal Bank of Canada26,736$897K0.0%-8.7%0.029% 5/15/2025 Paradigm Biocapital Advisors LP1,946,168$65.27M3.1%+1.9%2.079% 5/15/2025 Driehaus Capital Management LLC6,239,902$209.29M2.0%+1.6%6.664% 5/15/2025 Siren L.L.C.1,688,611$56.64M3.3%+4.9%1.804% 5/15/2025 Tema Etfs LLC58,807$1.97M0.6%+1.5%0.063% 5/14/2025 Affinity Asset Advisors LLC152,252$5.11M0.5%-66.9%0.163% 5/14/2025 Rafferty Asset Management LLC102,131$3.43M0.0%+25.7%0.109% 5/14/2025 Corebridge Financial Inc.44,896$1.51M0.0%+3.0%0.048% 5/14/2025 Comerica Bank997$33K0.0%-27.0%0.001% 5/14/2025 MetLife Investment Management LLC53,414$1.79M0.0%+0.7%0.057% 5/14/2025 Walleye Capital LLC123,982$4.16M0.0%-15.2%0.132% 5/14/2025 Jump Financial LLC18,800$631K0.0%N/A0.020% 5/14/2025 Martingale Asset Management L P6,701$225K0.0%-70.2%0.007% 5/14/2025 Price T Rowe Associates Inc. MD5,112,360$171.47M0.0%-5.6%5.460% 5/14/2025 Candriam S.C.A.488,911$16.40M0.1%N/A0.522% 5/14/2025 T. Rowe Price Investment Management Inc.689,265$23.12M0.0%-31.3%0.736% 5/14/2025 EntryPoint Capital LLC9,388$315K0.1%N/A0.010% 5/14/2025 Hsbc Holdings PLC13,489$439K0.0%+7.5%0.014% 5/14/2025 Wellington Management Group LLP6,891,397$231.14M0.0%-0.9%7.360% 5/13/2025 Northern Trust Corp857,081$28.75M0.0%-2.6%0.915% 5/13/2025 Algert Global LLC26,287$882K0.0%-8.7%0.028% 5/13/2025 Cresset Asset Management LLC14,898$500K0.0%+106.2%0.016% 5/13/2025 American Century Companies Inc.719,578$24.14M0.0%+50.8%0.769% 5/13/2025 Aberdeen Group plc208,059$6.98M0.0%+379.5%0.222% 5/13/2025 E Fund Management Co. Ltd.9,545$320K0.0%+65.3%0.010% New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how5/13/2025 Russell Investments Group Ltd.166,338$5.58M0.0%+386.4%0.178% 5/12/2025 Nuveen LLC562,935$18.88M0.0%N/A0.601% 5/12/2025 Invesco Ltd.69,959$2.35M0.0%-76.5%0.075% 5/12/2025 Swiss National Bank161,800$5.43M0.0%+1.5%0.173% 5/9/2025 Deutsche Bank AG204,122$6.85M0.0%-3.4%0.218% 5/9/2025 Charles Schwab Investment Management Inc.753,527$25.27M0.0%-0.7%0.805% 5/9/2025 Vanguard Group Inc.9,311,600$312.31M0.0%+2.4%9.945% 5/9/2025 PNC Financial Services Group Inc.3,395$114K0.0%+25.4%0.004% 5/8/2025 Commerce Bank6,320$212K0.0%+53.2%0.007% 5/8/2025 US Bancorp DE4,733$159K0.0%-25.0%0.005% 5/8/2025 Natixis Advisors LLC46,509$1.56M0.0%+1.8%0.050% 5/8/2025 Decheng Capital LLC177,958$5.97M1.7%+6.0%0.190% 5/7/2025 Fiera Capital Corp438,337$14.70M0.1%-3.7%0.468% 5/7/2025 Bryce Point Capital LLC17,371$611K0.5%-23.4%0.019% 5/7/2025 Zurcher Kantonalbank Zurich Cantonalbank 14,692$493K0.0%-2.7%0.016% 5/7/2025 TD Asset Management Inc174,694$5.86M0.0%-23.7%0.187% 5/6/2025 Universal Beteiligungs und Servicegesellschaft mbH342,734$11.50M0.0%+2.4%0.366% 5/5/2025 Lewis Asset Management LLC20,000$671K0.6%+104.5%0.021% 5/5/2025 GW&K Investment Management LLC920,020$30.86M0.3%+35.5%0.983% 5/5/2025 Teachers Retirement System of The State of Kentucky28,978$972K0.0%-19.2%0.031% 5/5/2025 Jennison Associates LLC2,119,767$71.10M0.0%-21.7%2.264% 5/2/2025 Segall Bryant & Hamill LLC146,274$4.91M0.1%-2.7%0.156% 5/2/2025 Victory Capital Management Inc.251,331$8.43M0.0%-10.7%0.268% 5/1/2025 New York State Common Retirement Fund137,918$4.63M0.0%-11.3%0.147% 5/1/2025 Arizona State Retirement System23,899$802K0.0%+1.8%0.026% 5/1/2025 Xponance Inc.6,857$230K0.0%+9.1%0.007% 4/30/2025 Alps Advisors Inc.67,303$2.26M0.0%-10.2%0.072% 4/30/2025 China Universal Asset Management Co. Ltd.18,664$626K0.1%-5.1%0.020% 4/29/2025 Envestnet Asset Management Inc.56,691$1.90M0.0%-10.1%0.061% 4/29/2025 GF Fund Management CO. LTD.2,375$80K0.0%+22.0%0.003% 4/29/2025 Moody Aldrich Partners LLC139,905$4.69M1.0%-3.1%0.149% 4/28/2025 Teacher Retirement System of Texas22,442$753K0.0%-6.5%0.024% 4/25/2025 Amalgamated Bank3,159$106K0.0%+17.3%0.003% 4/25/2025 KBC Group NV4,082$137K0.0%+10.0%0.004% 4/15/2025 SG Americas Securities LLC522,266$17.52M0.1%-3.7%0.561% 4/10/2025 Hennion & Walsh Asset Management Inc.32,580$1.09M0.0%-18.7%0.035% 4/8/2025 Rhumbline Advisers131,950$4.43M0.0%+6.3%0.142% 4/7/2025 GAMMA Investing LLC6,775$227K0.0%+6,291.5%0.007% 3/18/2025 California State Teachers Retirement System76,264$3.90M0.0%+18.8%0.082% 2/28/2025 Universal Beteiligungs und Servicegesellschaft mbH334,783$17.12M0.0%N/A0.361% 2/20/2025 Mackenzie Financial Corp5,422$277K0.0%+8.8%0.006% 2/19/2025 GF Fund Management CO. LTD.1,947$100K0.0%N/A0.002% 2/18/2025 Castleark Management LLC77,780$3.98M0.1%+6.1%0.084% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC325,276$16.63M0.0%+19.7%0.351% 2/17/2025 Woodline Partners LP50,000$2.56M0.0%N/A0.054% 2/17/2025 Soleus Capital Management L.P.85,000$4.35M0.3%N/A0.092% 2/17/2025 Two Sigma Advisers LP8,100$414K0.0%-63.8%0.009% 2/17/2025 State of Wyoming985$50K0.0%N/A0.001% 2/17/2025 Tema Etfs LLC57,933$2.96M1.2%N/A0.062% 2/17/2025 Stempoint Capital LP317,060$16.21M4.0%+48.3%0.342% New Rule Hits in July — The Smart Money Already Moved (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how2/17/2025 Rafferty Asset Management LLC81,257$4.16M0.0%-16.6%0.088% 2/17/2025 Point72 Asset Management L.P.2,788,939$142.60M0.3%+21.2%3.007% 2/17/2025 ProShare Advisors LLC29,089$1.49M0.0%+49.7%0.031% 2/17/2025 MPM Bioimpact LLC617,035$31.55M4.5%+17.3%0.665% 2/17/2025 Paradigm Biocapital Advisors LP1,910,761$97.70M3.4%-24.1%2.060% 2/17/2025 Parkman Healthcare Partners LLC51,133$2.61M0.3%-34.1%0.055% 2/17/2025 Nicholas Investment Partners LP127,283$6.51M0.6%+35.6%0.137% 2/17/2025Nuveen Asset Management LLC527,792$26.99M0.0%+2.6%0.569% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC27,687$1.42M0.1%+12.1%0.030% 2/17/2025 Orbimed Advisors LLC999,000$51.08M1.1%-4.9%1.077% (Data available from 1/1/2016 forward) CRNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRNX shares? During the previous two years, 217 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($456.49M), Vanguard Group Inc. ($312.31M), Wellington Management Group LLP ($231.14M), Driehaus Capital Management LLC ($209.29M), Farallon Capital Management LLC ($208.36M), Price T Rowe Associates Inc. MD ($171.47M), and State Street Corp ($145.05M).Learn more on CRNX's institutional investors. What percentage of Crinetics Pharmaceuticals stock is owned by institutional investors? 98.51% of Crinetics Pharmaceuticals stock is owned by institutional investors. Learn more on CRNX's institutional investor holdings. Which institutional investors have been buying Crinetics Pharmaceuticals stock? Of the 188 institutional investors that purchased Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.89M), Vanguard Group Inc. ($3.87M), Farallon Capital Management LLC ($3.41M), Jennison Associates LLC ($2.83M), Wellington Management Group LLP ($2.53M), Vestal Point Capital LP ($2.16M), and Janus Henderson Group PLC ($1.80M). How much institutional buying is happening at Crinetics Pharmaceuticals? Institutional investors have bought a total of 42,398,735 shares in the last 24 months. This purchase volume represents approximately $1.84B in transactions. Which Crinetics Pharmaceuticals major shareholders have been selling company stock? Of the 99 institutional investors that sold Crinetics Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Point72 Asset Management L.P. ($5.63M), Perceptive Advisors LLC ($1.62M), Braidwell LP ($1.37M), Frazier Life Sciences Management L.P. ($1.19M), First Light Asset Management LLC ($875.46K), Jennison Associates LLC ($673.85K), and Wellington Management Group LLP ($615.02K). How much institutional selling is happening at Crinetics Pharmaceuticals? Institutional investors have sold a total of 17,775,214 shares in the last 24 months. This volume of shares sold represents approximately $680.70M in transactions. Related Companies Ascendis Pharma A/S Institutional Ownership Moderna Institutional Ownership Viatris Institutional Ownership Qiagen Institutional Ownership Blueprint Medicines Institutional Ownership Roivant Sciences Institutional Ownership Revolution Medicines Institutional Ownership Verona Pharma Institutional Ownership BridgeBio Pharma Institutional Ownership Elanco Animal Health Institutional Ownership This page (NASDAQ:CRNX) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRNX Stock Free CRNX Stock Alerts